Hyalofast Cartilage Repair Matrix
A Single-Stage Hyaluronic Acid-Based Matrix to Repair Cartilage Lesions
Are you experiencing chronic pain, stiffness and limited function due to a cartilage injury or defect? One of Anika’s regenerative solutions uses a matrix comprised of hyaluronic acid, a vital component of healthy cartilage and tissue function, to offer patients a minimally invasive, single surgery option for cartilage repair and help them return to their active lifestyle.
Hyalofast® is a biodegradable matrix used to repair cartilage defects, called chondral or osteochondral lesions, depending on the severity and depth of the lesion. Hyalofast acts as a three-dimensional support for your mesenchymal stem cells. Once Hyalofast is implanted in the cartilage lesion, it fills the defect and progressively, through spontaneous degradation, enriches the implantation site with hyaluronic acid, while the mesenchymal stem cells grow into new cartilage, repairing your cartilage lesion. Hyalofast plays a major role in tissue repair. It facilitates the recovery of cartilage tissue by essentially trapping mesenchymal stem cells in the cartilage lesion to regenerate the tissue, essentially helping the body repair itself.
The unique design and handling properties of Hyalofast make it quickly and easily implantable via minimally invasive surgery. It permits a one-step cartilage repair surgery, avoiding the need for or cost of a second surgery. Clinical evidence shows Hyalofast has been clinically proven to be safe and effective in medium-to-long-term follow-up of 8 years to repair chondral or osteochondral lesions.
- Regenerative option to repair cartilage injuries
- One-step cartilage repair technique; no need for 2nd surgery
- Implanted in a minimally invasive procedure
- Safe: 100% hyaluronic acid-based material; not an animal-based product
- Biodegradable, implantable scaffold supports cartilage repair
If you are living with pain associated with a cartilage injury and want to avoid an invasive surgical intervention, talk to your doctor about Anika’s regenerative medicine solutions today.
Anika is currently enrolling patients in a U.S. clinical trial for Hyalofast.
Hyalofast is not approved for use in the United States.
Hyalofast is CE-marked indicated for the repair of chondral and osteochondral lesions.
Anika products may not be available in all geographies. Product availability is subject to the regulatory clearances in individual markets. Please reach out to your local representative or Contact Us if you have questions about specific market approvals.
For complete product information, including indications, contraindications, warnings, and precautions, please refer to the Instructions for Use provided with the product or Contact Us for a copy.